Combination therapies for managing cancer
US12377063B2 · kind B2 · utility
0Cited by
3References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 10, 2020 |
| Grant date | Aug 5, 2025 |
| Priority date | — |
| Expiry date | Oct 1, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are methods of managing cancer and tumor growth. This disclosure relates to methods of treating cancer comprising administering a combination of chemotherapy agents, wherein a first chemotherapy agent is capable of inhibiting oxidative phosphorylation of pyruvate and a second chemotherapy agent is capable of inhibiting glucose metabolism. In certain embodiments, the first and second chemotherapy agents are administered in combination with an additional chemotherapy agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.